Interferon regulatory factor-7 synergizes with other transcription factors through multiple interactions with p300/CBP coactivators
about
IRF7: activation, regulation, modification and functionConditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell developmentAbnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6)Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuitRegulatory serine residues mediate phosphorylation-dependent and phosphorylation-independent activation of interferon regulatory factor 7c-Fos as a proapoptotic agent in TRAIL-induced apoptosis in prostate cancer cellsRecruitment of histone deacetylase 3 to the interferon-A gene promoters attenuates interferon expressionNF-κB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1Promoter organization of the interferon-A genes differentially affects virus-induced expression and responsiveness to TBK1 and IKKepsilon.Soluble amyloid triggers a myeloid differentiation factor 88 and interferon regulatory factor 7 dependent neuronal type-1 interferon response in vitroTransforming growth factor beta/Smad3 signaling regulates IRF-7 function and transcriptional activation of the beta interferon promoter.Positive and negative control of virus-induced interferon-A gene expression.Aryl Hydrocarbon Receptor Interacting Protein Targets IRF7 to Suppress Antiviral Signaling and the Induction of Type I Interferon.Neonatal calf infection with respiratory syncytial virus: drawing parallels to the disease in human infantsThe role of type 1 interferon in systemic sclerosis.The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8.Induction and function of IFNβ during viral and bacterial infection.Epigenetics and the IRFs: a complex interplay in the control of immunity and autoimmunity.Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells.Transcriptional Repression of IFN Regulatory Factor 7 by MYC Is Critical for Type I IFN Production in Human Plasmacytoid Dendritic CellsEndoplasmic reticulum stress and the unfolded protein response are linked to synergistic IFN-beta induction via X-box binding protein 1.Regulation of the transcriptional activity of the IRF7 promoter by a pathway independent of interferon signaling.Cellular FLIP long isoform (cFLIPL)-IKKα interactions inhibit IRF7 activation, representing a new cellular strategy to inhibit IFNα expression.Dimerization of Phospho IRF3 or phospho IRF7Translocation of phosphorylated IRF3;IRF7 dimers into nucleusp-IRF7 dimer interacts with coactivator CBP/p300
P2860
Q24299740-3F24C35B-8B9F-415C-BD76-52B108E706A2Q24537650-87352F92-0FBF-412B-8484-FCD14B1515DDQ24675845-BDAE6562-7060-471A-8806-4563630FE113Q24683031-CA5E0E71-71CD-4BA4-97DD-CF13B495D833Q34016267-C8A79FF0-A783-46CF-BF40-F7B25020CCA2Q34139663-A5BFE3CB-398C-44C8-B88B-F8E7DA6B50F1Q34299600-28AD2859-4AD8-4844-B8F9-5B631C58D861Q34352790-797ED5EA-6C46-4146-9A02-2ACB9C5D4548Q34479875-8B417416-1DCC-4563-80C1-C7589E168D33Q35531082-9F883C44-400B-4437-8763-DBF85E895598Q35544657-36392DD2-1024-40F2-BB19-E89AE0EA40D9Q35675512-5674A3B6-9B61-4BC5-9C10-DC6CA35E42FFQ35860858-3908A235-2726-4844-87E6-89CCCCB84936Q36482799-1A014B10-61D4-41FD-AC91-DF8FBCB666EBQ37150404-35B7658F-50F4-4172-A0FA-9DB6ACAE8E9BQ37401277-4FBE43AD-67FA-45D6-B670-8EB05B44E65CQ37982838-27310317-198C-4553-8D5D-071EEDFF1205Q38161582-75DA30DE-5E74-4A95-BFD4-A5128B7B12C3Q38350682-1B3858B3-4901-4102-B231-DB0567543AA7Q38746231-C62F7B3A-0F44-4FFF-A2FA-DE89C9153163Q39620175-75E47E15-8C28-42A3-8E8E-19867AB1A98EQ40467468-0AC8F8F4-C02B-48AE-BA39-404F1198B3EDQ47313508-1DF09BBC-C247-404B-BE04-A8C66BE777E3Q50292018-70B919D3-D1F1-48E7-B572-2A6B594AC8F2Q50292019-0E8C9371-3F30-4FEB-B05C-8272F1DF27B2Q50292036-4C0DF7B0-0998-4018-9EA7-47AE1E5AD373
P2860
Interferon regulatory factor-7 synergizes with other transcription factors through multiple interactions with p300/CBP coactivators
description
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2003
@ast
im Mai 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/05/02)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/05/02)
@nl
наукова стаття, опублікована в травні 2003
@uk
name
Interferon regulatory factor-7 ...... ons with p300/CBP coactivators
@ast
Interferon regulatory factor-7 ...... ons with p300/CBP coactivators
@en
Interferon regulatory factor-7 ...... ons with p300/CBP coactivators
@nl
type
label
Interferon regulatory factor-7 ...... ons with p300/CBP coactivators
@ast
Interferon regulatory factor-7 ...... ons with p300/CBP coactivators
@en
Interferon regulatory factor-7 ...... ons with p300/CBP coactivators
@nl
prefLabel
Interferon regulatory factor-7 ...... ons with p300/CBP coactivators
@ast
Interferon regulatory factor-7 ...... ons with p300/CBP coactivators
@en
Interferon regulatory factor-7 ...... ons with p300/CBP coactivators
@nl
P2093
P2860
P356
P1476
Interferon regulatory factor-7 ...... ons with p300/CBP coactivators
@en
P2093
Charles H. Lin
Hongmei Yang
Marc G. Wathelet
Michael O. Baffi
P2860
P304
15495–15504
P356
10.1074/JBC.M212940200
P407
P577
2003-05-02T00:00:00Z